Randox Food Diagnostics has announced the release of an anthelmintics testing platform (EV3770), which can detect 25 analytes in total.
This multi-analyte testing array is used in conjunction with the Randox Biochip Array Technology and Evidence Investigator analyser.
The test menu includes avermectins, benzimidazoles, amino - benzimidazoles, Levamisole, thiabendazole, moxidectin and triclabendazole.
Anthelmintics are drugs that act against internal parasites of animals such as tapeworms, liver flukes and round worms that can cause helminthic infections.
The use of anthelmintic drugs can greatly improve livestock production; however, effective monitoring is required to ensure that residues are not passed into the human food chain.
Both parent and metabolite forms of the most commonly abused anthlemintic compounds can be detected.
These include albendazole sulphoxide and albendazole - two aminosulphones that are the main residues detected in tissue matrices irrespective of whether animals were dosed with netobimim, albendazole or albendazole sulphoxide.
The generic avermectin biochip can detect residues of ivermectin, abamectin, doramectin, emamectin benzoate and eprimomectin - all or some of which have been noted as marker residues in food by the EU, CODEX, Canada and the US.
According to Randox, excellent limits of detection are achieved in milk (0.05-3ppb) and in beef muscle (0.15-6.5ppb), ensuring compliance with most regulatory tolerance requirements is achieved.
